Akebia Therapeutics, Inc. (AKBA)

Akebia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	166.44	51.87	42.93	90.47	149.8	228.7
Short-Term Investments	-	-	-	-	-	39.99
Cash & Short-Term Investments	166.44	51.87	42.93	90.47	149.8	268.69
Cash Growth	389.27%	20.84%	-52.55%	-39.61%	-44.25%	81.92%
Receivables	66.22	34.37	39.29	40.28	55.89	28.58
Inventory	18.64	16.24	15.69	21.57	36.63	61.02
Prepaid Expenses	-	4.03	14.49	15.62	28.83	12.76
Restricted Cash	1.7	-	-	-	-	0.4
Other Current Assets	5.33	7.32	5.75	17.25	-	-
Total Current Assets	258.34	113.83	118.15	185.18	271.15	371.44
Property, Plant & Equipment	6.31	10.42	16.05	34.37	40.61	35.5
Goodwill	59.04	59.04	59.04	59.04	59.04	55.05
Other Intangible Assets	-	-	36.04	72.08	108.13	144.17
Other Long-Term Assets	40.46	37.38	12.42	5.37	50.42	37.98
Total Assets	364.15	220.67	241.7	356.05	529.35	644.14
Accounts Payable	10.09	15.18	14.64	18.02	33.59	41.31
Accrued Expenses	76.19	33.27	42.94	53.92	97.51	125.34
Current Portion of Long-Term Debt	15.14	4.31	19.55	32	97.54	-
Current Portion of Leases	4.94	5.4	4.49	4.74	4.8	5.29
Current Unearned Revenue	3.88	-	-	3.74	20.91	15.21
Other Current Liabilities	23.16	22.75	18.26	17.12	6.7	-
Total Current Liabilities	133.38	80.91	99.87	129.54	261.05	187.15
Long-Term Debt	178.94	175.47	111.29	91.56	53.08	96.38
Long-Term Leases	-	3.55	8.95	28.96	33.7	24.62
Long-Term Unearned Revenue	-	-	43.3	43.3	21.47	25.35
Other Long-Term Liabilities	10.24	9.93	8.89	57.47	86.03	63.03
Total Liabilities	322.56	269.86	272.29	350.82	455.34	396.52
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	1,713	1,629	1,578	1,562	1,537	1,425
Retained Earnings	-1,671	-1,678	-1,609	-1,557	-1,463	-1,178
Comprehensive Income & Other	0.01	0.01	0.01	0.01	0.01	0.01
Shareholders' Equity	41.59	-49.19	-30.58	5.23	74.01	247.62
Total Liabilities & Equity	364.15	220.67	241.7	356.05	529.35	644.14
Total Debt	199.01	188.73	144.28	157.27	189.13	126.29
Net Cash (Debt)	-32.56	-136.86	-101.35	-66.8	-39.33	142.41
Net Cash Growth	-	-	-	-	-	261.69%
Net Cash Per Share	-0.13	-0.65	-0.54	-0.37	-0.24	1.03
Filing Date Shares Outstanding	265.37	236.23	209.37	184.25	181.23	153.5
Total Common Shares Outstanding	265.23	224.85	194.58	184.14	177	148.07
Working Capital	124.96	32.92	18.28	55.65	10.1	184.29
Book Value Per Share	0.16	-0.22	-0.16	0.03	0.42	1.67
Tangible Book Value	-17.45	-108.23	-125.67	-125.9	-93.16	48.4
Tangible Book Value Per Share	-0.07	-0.48	-0.65	-0.68	-0.53	0.33
Machinery	-	-	-	-	5.85	5.79
Leasehold Improvements	-	-	-	-	8.57	8.57

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q